Skip to content

Evaluating the Effects of Artificial Intelligence-Aided Health Guidance on Personal Health Promotion: A Randomized Controlled Trial

Evaluating the Effects of Artificial Intelligence-Aided Health Guidance on Personal Health Promotion: A Randomized Controlled Trial - Evaluating the Effects of Artificial Intelligence-Aided Health Guidance on Personal Health Promotion

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043746
Enrollment
2720
Registered
2021-03-26
Start date
2021-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Health guidance will be provided using an AI-based health prediction results table, which will highlight items requiring improvement. Health guidance will be provided using the normal results table th

Sponsors

Department of Health Sciences, Faculty of Medicine, University of Yamanashi.
Lead Sponsor
Yamanashi Koseiren Health Care Center
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Examinees who undergo health-checkups at Yamanashi Koseiren Health Care Center from April 1, 2021, to March 31, 2023, and meet the following conditions. (1) Received a health-checkup at the same facility in the previous year. (2) Body mass index (BMI) at the time of examination in the previous year was 22 or higher. (3) The age at the time of health-checkup is 74 years or younger. (4) Patients who answered that they do not have regular hospital visits. (5) Patients who give written consent for participation in this study. (Registrations from April 1, 2022 to March 31, 2023 is limited to the situation where the required number of cases could not be collected in the fiscal year 2021.)

Exclusion criteria

Exclusion criteria: The exclusion criteria include: (1) Participants under 16 years of age. (2) Patients unable to receive health guidance by staff due to physical, mental, or other reasons or who are expected to be constrained in the quality of health guidance.

Design outcomes

Primary

MeasureTime frame
Mean change in body mass index (BMI) values between the intervention year and the following year for each group.

Secondary

MeasureTime frame
Mean change in the following parameters between the intervention year and the following year for each group: Weight, abdominal circumference, blood pressure (systolic, diastolic), liver function (AST, ALT, GTP), lipids (triglycerides, LDL/HDL cholesterol), blood glucose (fasting blood glucose, HbA1c), renal function (creatinine, eGFR), uric acid level, each questionnaire in the physical examination, and questions to be prepared for the study.

Countries

Japan

Contacts

Public ContactTadao Ooka

Faculty of Medicine, University of Yamanashi Department of Health Sciences

tohoka@yamanashi.ac.jp0552739566

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026